Serum profiling for identification of autoantibody signatures in diseases using protein microarrays

Autoantigenomics: holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases

CP Moritz, S Paul, O Stoevesandt, Y Tholance… - Autoimmunity …, 2020 - Elsevier

Autoimmune diseases are mostly characterized by autoantibodies in the patients' serum or
cerebrospinal fluid, representing diagnostic or prognostic biomarkers. For decades …

被引用次数：35 相关文章所有 5 个版本

[PDF] google.com

Evaluation of autoantibody signatures in pituitary adenoma patients using human proteome arrays

A Banerjee, A Ray, A Barpanda, A Dash… - PROTEOMICS …, 2022 - Wiley Online Library

Purpose To identify the specific diagnostic biomarkers related to pituitary adenomas (PAs),
we performed serological antibody profiles for three types of PAs, namely Acromegaly …

被引用次数：8 相关文章所有 5 个版本

Immunoproteomics methods and techniques

KM Fulton, I Baltat, SM Twine - Immunoproteomics: methods and protocols, 2019 - Springer

The varied landscape of the adaptive immune response is determined by the peptides
presented by immune cells, derived from viral or microbial pathogens or cancerous cells …

被引用次数：13 相关文章所有 4 个版本

Discovery of potential biomarkers for lung cancer classification based on human proteome microarrays using Stochastic Gradient Boosting approach

N Yao, J Pan, X Chen, P Li, Y Li, Z Wang, T Yao… - Journal of Cancer …, 2023 - Springer

Purpose Early identification of lung cancer (LC) will considerably facilitate the intervention
and prevention of LC. The human proteome micro-arrays approach can be used as a “liquid …